| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 1.1 | 0.05 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.086 | 0.06 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.06 |